FESK.COMYour global study desk
Email us
Home › Scholar › Ha Thanh Vu
COMPILEDopen profilenot managed by this scholar
H

Ha Thanh Vu

Researcher Profile 6/10
Vietnam Academy of Social Sciences · Medicine and Pharmacy
19 publications · 351 citations · h-index 3
This is my profile

Information

Featured publications

Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults181 citations
Journal of Clinical Oncology · 2003 · DOI
Sequence of Radiotherapy With Tamoxifen in Conservatively Managed Breast Cancer Does Not Affect Local Relapse Rates101 citations
Journal of Clinical Oncology · 2004 · DOI
BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.64 citations
PubMed · 2000
Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam3 citations
Therapeutic Advances in Medical Oncology · 2024 · DOI
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam1 citations
Therapeutic Advances in Medical Oncology · 2025 · DOI
A Real-World Cohort Study of First-Line Afatinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer in Vietnam1 citations
Research Square · 2023 · DOI
Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI
Hiệu quả điều trị pembrolizumab phối hợp với lenvatinib trong ung thư biểu mô tế bào thận giai đoạn di căn: 2 ca lâm sàng
Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế · 2025 · DOI
RESULTS OF CHEMOTHERAPY PACLITAXEL- CARBOPLATIN TREATMENT IN METASTATIC THYMIC CARCINOMA AT K HOSPITAL
Tạp chí Ung thư học Việt Nam · 2025 · DOI
Author response for "Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam"
· 2025 · DOI

About the field of Medicine and Pharmacy

6,619researchers 91,896publications 2,589,484citations 4.2average h-index

Common research topics in this field:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Institutions with the most researchers in this field:

Hanoi Medical University · 422 University of Medicine and Pharmacy at Ho Chi Minh City · 418 Vietnam National University Ho Chi Minh City · 393 Can Tho University · 311 Hue University · 240

These figures count profiles currently in this directory, not nationwide statistics.

Same institution — Vietnam Academy of Social Sciences

N
Nguyen Xuan Anh
Earth Sciences
T
Tien Quang Tran
Economics
N
Nguyen Tran Dinh
Agriculture
L
Long Vu
Biology
N
Nguyen Bich Thu
Pharmacy
A
Anh Nguyen Dang
Biology

Same field Medicine and Pharmacy

N
Nguyen Do Huy
Vietnam National Children'
C
Chien Van Tran
Vietnam National Universit
L
Luong Cong Thuc
Vietnam Military Medical U
T
Tu Anh Hoang
H
Huyen Nguyen
RMIT Vietnam University
H
H.-V.T. Tran
Pham Ngoc Thach University
Verify at: ORCID Find works on Google Scholar ↗ Search Google ↗
The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗

Suggest / Claim this profile

  
Profile aggregated from public sources. We respect scholars' rights to edit and remove information — all requests are processed promptly.
Ha Thanh VuVietnam Academy of Social Sciences
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.